Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19.
COVID-19
age
anti-SARS-CoV-2 vaccination
in-hospital death
mechanical ventilation
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
01 Apr 2022
01 Apr 2022
Historique:
received:
04
03
2022
revised:
29
03
2022
accepted:
30
03
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
24
4
2022
Statut:
epublish
Résumé
Whether vaccination confers a protective effect against progression after hospital admission for COVID-19 remains to be elucidated. Observational study including all the patients admitted to San Paolo Hospital in Milan for COVID-19 in 2021. Previous vaccination was categorized as: none, one dose, full vaccination (two or three doses >14 days before symptoms onset). Data were collected at hospital admission, including demographic and clinical variables, age-unadjusted Charlson Comorbidity index (CCI). The highest intensity of ventilation during hospitalization was registered. The endpoints were in-hospital death (primary) and mechanical ventilation/death (secondary). Survival analysis was conducted by means of Kaplan-Meier curves and Cox regression models. Effect measure modification by age was formally tested. We included 956 patients: 151 (16%) fully vaccinated (18 also third dose), 62 (7%) one dose vaccinated, 743 (78%) unvaccinated. People fully vaccinated were older and suffering from more comorbidities than unvaccinated. By 28 days, the risk of death was of 35.9% (95%CI: 30.1−41.7) in unvaccinated, 41.5% (24.5−58.5) in one dose and 28.4% (18.2−38.5) in fully vaccinated (p = 0.63). After controlling for age, ethnicity, CCI and month of admission, fully vaccinated participants showed a risk reduction of 50% for both in-hospital death, AHR 0.50 (95%CI: 0.30−0.84) and for mechanical ventilation or death, AHR 0.49 (95%CI: 0.35−0.69) compared to unvaccinated, regardless of age (interaction p > 0.56). Fully vaccinated individuals in whom vaccine failed to keep them out of hospital, appeared to be protected against critical disease or death when compared to non-vaccinated. These data support universal COVID-19 vaccination.
Identifiants
pubmed: 35455299
pii: vaccines10040550
doi: 10.3390/vaccines10040550
pmc: PMC9031136
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : HORIZON-HLTH-2021-CORONA-01
ID : 101046016
Références
MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(4):139-145
pubmed: 35085224
Lancet. 2021 Dec 4;398(10316):2093-2100
pubmed: 34756184
Nature. 2021 Dec;600(7888):197-199
pubmed: 34857948
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Lancet. 2022 Jan 29;399(10323):437-446
pubmed: 35065011
Clin Microbiol Infect. 2022 Jun;28(6):871-878
pubmed: 35219807
MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1284-1290
pubmed: 34529637
N Engl J Med. 2021 Dec 23;385(26):2413-2420
pubmed: 34879190
Cancer Invest. 1992;10(6):525-31
pubmed: 1422890
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
JAMA. 2021 Nov 23;326(20):2043-2054
pubmed: 34734975
Life (Basel). 2021 Sep 17;11(9):
pubmed: 34575128
Int J Infect Dis. 2020 Nov;100:67-74
pubmed: 32950738
BMC Infect Dis. 2020 Nov 27;20(1):897
pubmed: 33246431
Environ Res. 2021 Apr;195:110777
pubmed: 33485909
BMJ. 2021 Dec 23;375:n3144
pubmed: 34949600
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Nature. 2021 Dec;600(7890):577-578
pubmed: 34934198
Lancet Infect Dis. 2021 Nov;21(11):e342-e347
pubmed: 34019801
Euro Surveill. 2021 Nov;26(47):
pubmed: 34823641
N Engl J Med. 2021 Dec 23;385(26):2487-2489
pubmed: 34818474
Lancet Public Health. 2020 Jun;5(6):e310
pubmed: 32339478
Ann Epidemiol. 2021 May;57:14-21
pubmed: 33662494